Rodent model of prostate cancer
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- REGENERON PHARM INC
- Publication Date
- 2018-06-08
- Estimated Expiration
- Not applicable · inactive patent
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
[0001] Cross References to Related Applications
[0002] This application claims the benefit of priority to US Provisional Application No. 62 / 213,389, filed September 2, 2015, the entire contents of which are incorporated herein by reference. field of invention
[0003] The present disclosure relates to a rodent model of prostate cancer. The rodents disclosed herein comprise a transgene comprising the SV40 tumor antigen coding sequence operably linked to the 5' and 3' regulatory regions of the mouse probasin gene. The rodents disclosed herein exhibit prostate-specific expression of the transgene and develop progressive forms of prostate tumors that mimic the development of human prostate cancer.
[0004] The sequence listing is incorporated by reference
[0005] The sequence listing is an ASCII text file named 32350_10161US01_SequenceListing.txt with a size of 440KB created on August 24, 2016, submitted to the US Patent and Trademark Office via EFS-Web, and incorporated here...